Table 5.
Events in 6 months versus 3 years
| 6-month follow-up (n = 121) | 3-year follow-up (n = 119) | |||||
|---|---|---|---|---|---|---|
| Invasive (n = 80) | Conservative (n = 41) | P value | Invasive (79) | Conservative (40) | P value | |
| Death/Re-MI | 14 % (11) | 0 % | 0.015 | 20 % (16) | 0 % | 0.002 |
| Re-PCI | 13 % (10) | 22 % (9) | ns | 19 % (15) | 32.5 % (14) | ns |
| - Re- PCI NCL | 7.5 % (6) | 22 % (9) | 0.004 | 8.9 % (7) | 32.5 % (13) | 0.001 |
| - Re-PCI CL | 5.5 % (4) | 0 % | ns | 10 % (8) | 0 % | 0.05 |
| CABG | 6.3 %(5) | 0 % | ns | 15 %(12) | 2.5 %(1) | 0.05 |
| MACE | 21 %(17) | 22 %(9) | ns | 35 %(28) | 35 %(14) | ns |
CABG coronary artery bypass graft, MACE major adverse cardiac events, MI myocardial infarction, PCI percutaneous coronary intervention